• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rituximab-induced coagulopathy.

作者信息

Novak Jan, Mocikova Heidi, Pavlicek Petr, Gaherova Lubica, Kozak Tomas

出版信息

Leuk Lymphoma. 2012 Nov;53(11):2299-301. doi: 10.3109/10428194.2012.682313. Epub 2012 May 16.

DOI:10.3109/10428194.2012.682313
PMID:22480246
Abstract
摘要

相似文献

1
Rituximab-induced coagulopathy.利妥昔单抗诱导的凝血病。
Leuk Lymphoma. 2012 Nov;53(11):2299-301. doi: 10.3109/10428194.2012.682313. Epub 2012 May 16.
2
Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenström macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combination.利妥昔单抗诱导的危及生命的凝血病发生在一名接受氟达拉滨、环磷酰胺和利妥昔单抗联合治疗的华氏巨球蛋白血症患者身上。
Leuk Lymphoma. 2010 Dec;51(12):2288-90. doi: 10.3109/10428194.2010.523127. Epub 2010 Oct 7.
3
[Interstitial pneumonitis related to rituximab therapy in primary macroglobulinemia: a case report and literatures review].
Zhonghua Xue Ye Xue Za Zhi. 2014 Nov;35(11):1022-3. doi: 10.3760/cma.j.issn.0253-2727.2014.11.017.
4
Very late onset hepatitis-B virus reactivation following rituximab despite lamivudine prophylaxis: the need for continued vigilance.
Leuk Lymphoma. 2014 Apr;55(4):938-9. doi: 10.3109/10428194.2013.813502. Epub 2013 Nov 12.
5
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab.一名使用利妥昔单抗的患者发生颌骨骨坏死与POEMS综合征的关联。
J Craniomaxillofac Surg. 2014 Jun;42(4):279-82. doi: 10.1016/j.jcms.2013.05.014. Epub 2013 Jun 22.
6
The optimized anti-CD20 monoclonal antibody ublituximab bypasses natural killer phenotypic features in Waldenström macroglobulinemia.优化后的抗CD20单克隆抗体ublituximab可绕过华氏巨球蛋白血症中的自然杀伤细胞表型特征。
Haematologica. 2015 Apr;100(4):e147-51. doi: 10.3324/haematol.2014.118083. Epub 2014 Dec 31.
7
Unresolved issues in the comparison of therapies and determination of responses in Waldenström macroglobulinemia.
Leuk Lymphoma. 2010 Oct;51(10):1767-70. doi: 10.3109/10428194.2010.509455.
8
Fludarabine, cyclophosphamide and rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia.
Leuk Lymphoma. 2008 Jun;49(6):1209-11. doi: 10.1080/10428190802007718.
9
Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen.维持利妥昔单抗治疗与对利妥昔单抗治疗方案有反应的初治华氏巨球蛋白血症患者的临床结局改善相关。
Br J Haematol. 2011 Aug;154(3):357-62. doi: 10.1111/j.1365-2141.2011.08750.x. Epub 2011 May 25.
10
What's new in Waldenström macroglobulinemia.华氏巨球蛋白血症的新进展
Leuk Lymphoma. 2010 Oct;51(10):1765-6. doi: 10.3109/10428194.2010.504959.

引用本文的文献

1
Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system.药物性凝血病：一项使用美国食品药品监督管理局不良事件报告系统的真实世界药物警戒研究。
Front Pharmacol. 2024 Dec 18;15:1486422. doi: 10.3389/fphar.2024.1486422. eCollection 2024.
2
[Rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma: a case report and literature review].[利妥昔单抗致脾边缘区淋巴瘤患者急性血小板减少症：1例报告及文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):338-342. doi: 10.3760/cma.j.issn.0253-2727.2021.04.012.
3
Disseminated Intravascular Coagulation-like Reaction after Rituximab Infusion in a Patient with Nephrotic Syndrome.
一名肾病综合征患者在输注利妥昔单抗后出现弥散性血管内凝血样反应。
Intern Med. 2019 Jul 15;58(14):2057-2061. doi: 10.2169/internalmedicine.2236-18. Epub 2019 Mar 28.
4
Disseminated intravascular coagulation-like reaction following rituximab infusion.利妥昔单抗输注后出现弥散性血管内凝血样反应。
BMJ Case Rep. 2017 Feb 8;2017:bcr2016218443. doi: 10.1136/bcr-2016-218443.
5
Monoclonal antibody therapy and renal transplantation: focus on adverse effects.单克隆抗体治疗与肾移植：关注不良反应。
Toxins (Basel). 2014 Feb 28;6(3):869-91. doi: 10.3390/toxins6030869.